摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

硫代吗啉-3-羧酸乙酯 | 58729-31-0

中文名称
硫代吗啉-3-羧酸乙酯
中文别名
——
英文名称
ethyl thiomorpholine-3-carboxylate
英文别名
ethyl perhydro-1,4-thiazine-3-carboxylate;ethyl 3-thiomorpholinecarboxylate;3-carbethoxythiomorpholine;thiomorpholine-3-carboxylic acid ethyl ester;thiomorpholin-3-ylcarboxylic acid ethyl ester;1.4-Thiamorpholin-carbonsaeure-(3)-aethylester
硫代吗啉-3-羧酸乙酯化学式
CAS
58729-31-0
化学式
C7H13NO2S
mdl
MFCD00107967
分子量
175.252
InChiKey
PGSDSYPPZAPZCW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    118 °C
  • 沸点:
    114-118℃ (7-8 Torr)
  • 密度:
    1.122±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    11
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.857
  • 拓扑面积:
    63.6
  • 氢给体数:
    1
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2934999090

SDS

SDS:791a06ba6769b5bd84a8c8c8ea6158cd
查看
Name: Ethyl thiomorpholine-3-carboxylate Material Safety Data Sheet
Synonym:
CAS: 58729-31-0
Section 1 - Chemical Product MSDS Name:Ethyl thiomorpholine-3-carboxylate Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
58729-31-0 Ethyl thiomorpholine-3-carboxylate 97+% unlisted
Hazard Symbols: C
Risk Phrases: 34

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 58729-31-0: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Pale yellow
Odor: Without to slight
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 118 - 121 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H13NO2S
Molecular Weight: 175.25

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, reducing agents, strong bases, amines.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 58729-31-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Ethyl thiomorpholine-3-carboxylate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.*
Hazard Class: 8
UN Number: 3259
Packing Group: III
IMO
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 3259
Packing Group: III
RID/ADR
Shipping Name: AMINES, SOLID, CORROSIVE, N.O.S.
Hazard Class: 8
UN Number: 3259
Packing group: III

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 22 Do not breathe dust.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 58729-31-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 58729-31-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 58729-31-0 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Larsson, Ulf; Carlson, Rolf, Acta Chemica Scandinavica, 1994, vol. 48, # 6, p. 517 - 525
    摘要:
    DOI:
  • 作为产物:
    描述:
    2,6-二甲基吡啶calcium sulfate 、 copper(II) bis(trifluoromethanesulfonate) 作用下, 以 二氯甲烷 为溶剂, 反应 12.0h, 以59%的产率得到硫代吗啉-3-羧酸乙酯
    参考文献:
    名称:
    SnAP试剂可将醛转化为取代的硫吗啉—一种与饱和杂环交叉偶联的替代方法
    摘要:
    这是SnAP!醛向N-未取代的3-硫代吗啉的转化为金属催化的交叉偶联反应提供了一种方便的替代方法,而金属催化的交叉偶联反应通常不适合饱和N-杂环的功能化。铜介导的自由基环化是这些试剂提供的温和条件,高官能团耐受性和广泛底物范围的关键。
    DOI:
    10.1002/anie.201208064
点击查看最新优质反应信息

文献信息

  • 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US05102877A1
    公开(公告)日:1992-04-07
    1-Azabicyclo[3.2.0]hept-2-ene-2-carboxyic acids having antimicrobial activity have been prepared.
    具有抗微生物活性的1-氮杂二环[3.2.0]庚-2-烯-2-羧酸已制备。
  • Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
    申请人:Gangloff Anthony R.
    公开号:US20100190763A1
    公开(公告)日:2010-07-29
    Disclosed are compounds of the following formula: in which R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , X, and t are defined in the specification. Also disclosed are pharmaceutical compositions, kits, and articles of manufacture, which contain the compounds, methods and intermediates useful for making the compounds, and methods of using the compounds to treat diseases, disorders, and conditions related to PARP activity.
    披露了以下公式的化合物: 其中R1、R2、R3、R4、R5、R6、R7、X和t在规范中定义。还披露了含有这些化合物的药物组合物、试剂盒和制造物品,以及用于制备这些化合物的方法和中间体,以及使用这些化合物治疗与PARP活性相关的疾病、紊乱和状况的方法。
  • [EN] TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY, SUBSTITUTED IN POSITION 3 BY A NON-AROMATIC RING CARRYING A HALOALKYL SUBSTITUENT<br/>[FR] TRITERPÉNOÏDES PRÉSENTANT UNE ACTIVITÉ D'INHIBITION DE LA MATURATION DU VIH, SUBSTITUÉS EN 3ÈME POSITION PAR UN CYCLE NON AROMATIQUE PORTANT UN SUBSTITUANT HALOGÉNOALKYLE
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2015157483A1
    公开(公告)日:2015-10-15
    Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, triterpenoids that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: with X selected from C4-8 cycloalkyl, C4-8 cycloalkenyl, C4-9 spirocycloalkyl, C4-9 spirocycloalkenyl, C4-8 oxacycloalkyl, C4-8 dioxacycloalkyl, C6-8 oxacycloalkenyl, C6-8 dioxacycloalkenyl, C6 cyclodialkenyl, C6 oxacyclodialkenyl, C6-9 oxaspirocycloalkyl and C6-9 oxaspirocycloalkenyl ring, such that X is substituted with A, wherein A is -C1-6 alkyl- halo. These compounds are useful for the treatment of HIV and AIDS.
    具有药物和生物活性的化合物、其药物组合物及其用途被详细阐述。特别是,提供了一种具有独特抗病毒活性的三萜类化合物,作为HIV成熟抑制剂,由公式I的化合物表示:其中X选自C4-8环烷基、C4-8环烯基、C4-9螺环烷基、C4-9螺环烯基、C4-8氧环烷基、C4-8二氧环烷基、C6-8氧环烯基、C6-8二氧环烯基、C6二烯基、C6氧二烯基、C6-9氧螺环烷基和C6-9氧螺环烯基环,使得X被A取代,其中A是- C1-6烷基-卤素。这些化合物用于治疗HIV和艾滋病。
  • Discovery and Synthesis of HIV Integrase Inhibitors:  Development of Potent and Orally Bioavailable N-Methyl Pyrimidones
    作者:Cristina Gardelli、Emanuela Nizi、Ester Muraglia、Benedetta Crescenzi、Marco Ferrara、Federica Orvieto、Paola Pace、Giovanna Pescatore、Marco Poma、Maria del Rosario Rico Ferreira、Rita Scarpelli、Carl F. Homnick、Norihiro Ikemoto、Anna Alfieri、Maria Verdirame、Fabio Bonelli、Odalys Gonzalez Paz、Marina Taliani、Edith Monteagudo、Silvia Pesci、Ralph Laufer、Peter Felock、Kara A. Stillmock、Daria Hazuda、Michael Rowley、Vincenzo Summa
    DOI:10.1021/jm0704705
    日期:2007.10.1
    reverse transcriptase, a protease, and an integrase. The latter is responsible for the integration of the viral genome into the human genome and, therefore, represents an attractive target for chemotherapeutic intervention against AIDS. A drug based on this mechanism has not yet been approved. Benzyl-dihydroxypyrimidine-carboxamides were discovered in our laboratories as a novel and metabolically stable
    人类1型免疫缺陷病毒(HIV-1)编码三种对于病毒复制必不可少的酶:逆转录酶,蛋白酶和整合酶。后者负责将病毒基因组整合到人类基因组中,因此代表了对AIDS进行化学疗法干预的诱人靶标。基于这种机制的药物尚未获得批准。在我们的实验室中发现苄基-二羟基嘧啶-羧酰胺是一类新型的,代谢稳定的药物,对HIV整合酶链转移步骤具有有效的抑制作用。进一步的努力导致了基于结构相关的N-Me嘧啶酮骨架的非常有效的化合物。该系列中最有趣的化合物之一是2-N-Me-吗啉代衍生物27a,其显示在血清存在下细胞中的CIC95为65 nM。该化合物在三种临床前物种中均具有良好的药代动力学特性,并且在几种抗筛选试验中未显示任何责任。
  • 1-(3-heterocyclylphenyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal
    申请人:American Cyanamid Company
    公开号:US05610120A1
    公开(公告)日:1997-03-11
    There is provided a 1-(3-heterocyclylphenyl)-s-triazine-2,4,6-oxo or thiotrione compound having the structural formula I ##STR1## Further provided are a composition and a method comprising that compound for the control of undesirable plant species.
    提供一种具有结构式I的1-(3-杂环基苯基)-s-三嗪-2,4,6-酮或硫代三嗪化合物。进一步提供了一种包含该化合物的组合物和方法,用于控制不良植物物种。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物